In addition to the documented ability of IL-7 to induce reactivation of latent HIV-1 in resting cells from patients [19], [20], recombinant IL-7 (rIL-7) has shown efficacy in combating lymphopenia when administered to HIV-1 patients [27]. Here, IL7 is linked to lymphopenia.